Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 2475
Gene Symbol: MTOR
MTOR
0.010 Biomarker group BEFREE Tuberous sclerosis complex (TSC) is a genetic disease related to hyperactivation of the mechanistic target of rapamycin (mTOR) pathway and manifested by neurological symptoms, such as epilepsy and sleep disorders. 31605778 2020
Entrez Id: 6272
Gene Symbol: SORT1
SORT1
0.010 Biomarker group BEFREE Meta-analysis using random effect model was done to estimate the prevalence of neurological symptoms per class of antibody described in SORT1 and SORT2 articles. 31731087 2020
Entrez Id: 10273
Gene Symbol: STUB1
STUB1
0.010 Biomarker group BEFREE CCAS is a prominent and often early feature of SCA48 which may be followed years after the onset of the disease by other complex neurological signs and symptoms. 31741143 2020
Entrez Id: 60
Gene Symbol: ACTB
ACTB
0.010 Biomarker group BEFREE In conclusion, we demonstrate that PHEV utilizes the integrin α5β1-FAK-Rac1/Cdc42-PAK-LIMK-cofilin pathway to cause an actin cytoskeletal rearrangement to promote its own invasion, providing theoretical support for the development of PHEV pathogenic mechanisms and new antiviral targets.<b>IMPORTANCE</b> PHEV, a member of the <i>Coronaviridae</i> family, is a typical neurotropic virus that primarily affects the nervous system of piglets to produce typical neurological symptoms. 30541856 2019
Entrez Id: 4000
Gene Symbol: LMNA
LMNA
0.010 GeneticVariation group BEFREE Many patients with an LMNA mutation have neurologic symptoms by their 30s and develop progressive cardiac manifestations during the next decade. 31476771 2019
Entrez Id: 6310
Gene Symbol: ATXN1
ATXN1
0.010 Biomarker group BEFREE Spinocerebellar ataxia (SCA) type 1 (SCA1) is a rare autosomal dominant disorder that is characterized by worsening of disordered coordination, ataxia of the trunk, and other neurological symptoms. 31271500 2019
Entrez Id: 63973
Gene Symbol: NEUROG2
NEUROG2
0.010 AlteredExpression group BEFREE In this study, we differentiated human induced pluripotent stem cells (iPSCs) from a female patient with TSC with one or two mutations in <i>TSC2</i> into neurons using induced expression of NGN2 to examine neuronal dysregulation associated with the neurological symptoms in TSC. 31591157 2019
Entrez Id: 3146
Gene Symbol: HMGB1
HMGB1
0.010 Biomarker group BEFREE We hypothesized that HMGB1 released from damaged cells in pituitary apoplexy would exacerbate the neurological symptoms due to acute inflammation. 31366550 2019
Entrez Id: 7450
Gene Symbol: VWF
VWF
0.010 Biomarker group BEFREE Statistical analysis showed that loss of VWF-HMWM as assessed by VWF:CB < 70 IU/dL is associated with detectable anti-ADAMTS13 antibodies, severe neurological symptoms and thrombocytopenia (p < 0.05). 31330376 2019
Entrez Id: 7249
Gene Symbol: TSC2
TSC2
0.010 GeneticVariation group BEFREE It is generally believed that the neurological symptoms associated with loss of PTEN and other mTORopathies (for example, mutations in the tuberous sclerosis genes TSC1 or TSC2) are due to hyperactivation of mTORC1-mediated protein synthesis<sup>1,2,4,6,7</sup>. 31636454 2019
Entrez Id: 25793
Gene Symbol: FBXO7
FBXO7
0.010 Biomarker group BEFREE Despite these phenotypes, Fbxo7 hypomorphs were produced at a normal Mendelian ratio with a normal lifespan and no evidence of neurological symptoms. 30840666 2019
Entrez Id: 3082
Gene Symbol: HGF
HGF
0.010 GeneticVariation group BEFREE Intramuscular delivery of HGF-expressing recombinant AAV improves muscle integrity and alleviates neurological symptoms in the nerve crush and SOD1-G93A transgenic mouse models. 31376938 2019
Entrez Id: 6657
Gene Symbol: SOX2
SOX2
0.010 Biomarker group BEFREE SOX2 antibodies are specific (>90%) markers for SCLC, but are rarely found in patients with other tumours, whether neurological symptoms are present or not. 30445363 2019
Entrez Id: 3596
Gene Symbol: IL13
IL13
0.010 Biomarker group BEFREE In addition, the higher Th1 cells (IL-2, TNF-α, and TNF-β), Th2 cells (IL-13), and Th17 (TGF-β1, IL-23) and the course of WD were associated with the severity of the neurological symptoms for WD patients. 30644005 2019
Entrez Id: 211
Gene Symbol: ALAS1
ALAS1
0.010 AlteredExpression group BEFREE Acute porphyric attacks, precipitated by fasting, certain hormones and some drugs, involve induction of 5-ALAS secondarily to depletion of the above pool, and the resultant elevation of 5-ALA levels initiates the abdominal and neurological symptoms of attacks. 31443750 2019
Entrez Id: 7422
Gene Symbol: VEGFA
VEGFA
0.010 Biomarker group BEFREE Our results show an association between VEGF and Clusterin and neurological symptoms of patients with high-grade carotid artery stenosis. 30952532 2019
Entrez Id: 6506
Gene Symbol: SLC1A2
SLC1A2
0.010 Biomarker group BEFREE Various therapeutic interventions to restore GLT-1, their proposed mechanism of action and functional effects will be examined as potential treatments to attenuate the neurological symptoms associated with loss or downregulation of GLT-1. 31338020 2019
Entrez Id: 1621
Gene Symbol: DBH
DBH
0.010 GeneticVariation group BEFREE Polymorphisms of DBH have been reported to be associated with several neurological diseases, such as Parkinson's disease, Alzheimer's disease, schizophrenia and attention-deficit hyperactivity disorder, which have overlapping neurological symptoms with WD. 31265749 2019
Entrez Id: 1191
Gene Symbol: CLU
CLU
0.010 Biomarker group BEFREE Our results show an association between VEGF and Clusterin and neurological symptoms of patients with high-grade carotid artery stenosis. 30952532 2019
Entrez Id: 51561
Gene Symbol: IL23A
IL23A
0.010 GeneticVariation group BEFREE In addition, the higher Th1 cells (IL-2, TNF-α, and TNF-β), Th2 cells (IL-13), and Th17 (TGF-β1, IL-23) and the course of WD were associated with the severity of the neurological symptoms for WD patients. 30644005 2019
Entrez Id: 84816
Gene Symbol: RTN4IP1
RTN4IP1
0.010 GeneticVariation group BEFREE Patients with RTN4IP1 mutations show early-onset optic neuropathy that can be followed by additional neurological symptoms such as seizures, ataxia, mental retardation, or even severe encephalopathy. 31077085 2019
Entrez Id: 5230
Gene Symbol: PGK1
PGK1
0.010 GeneticVariation group BEFREE We present a 20-year-old male with a novel c.461T>C (p.L154P) PGK1 mutation and clinical disease complicated by anemia and neurological symptoms. 30951021 2019
Entrez Id: 10577
Gene Symbol: NPC2
NPC2
0.010 GeneticVariation group BEFREE Niemann-Pick type C (NPC) is a lysosomal lipid storage disease with mutation of NPC1/NPC2 genes, which transport lipids in the endosome and lysosome, and various neurological symptoms. 30737051 2019
Entrez Id: 493856
Gene Symbol: CISD2
CISD2
0.010 GeneticVariation group BEFREE Wolfram syndrome is a rare multisystem disorder caused by mutations in WFS1 or CISD2 genes leading to brain structural abnormalities and neurological symptoms. 31796109 2019
Entrez Id: 6288
Gene Symbol: SAA1
SAA1
0.010 AlteredExpression group BEFREE After introducing TCZ, her neurological symptoms and MRI findings gradually improved.SAA levels remained low. 31277158 2019